Symbols / COO Stock $63.09 -1.94% The Cooper Companies, Inc.

Healthcare • Medical Instruments & Supplies • United States • NMS
COO (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. Albert G. White III
Exch · Country NMS · United States
Market Cap 12.31B
Enterprise Value 14.96B
Income 401.40M
Sales 4.15B
FCF (ttm) 367.09M
Book/sh 42.87
Cash/sh 0.64
Employees 15,000
Insider 10d —
IPO Jan 21, 1983
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 31.39
Forward P/E 12.57
PEG 1.68
P/S 2.96
P/B 1.47
P/C —
EV/EBITDA 13.61
EV/Sales 3.60
Quick Ratio 0.58
Current Ratio 1.34
Debt/Eq 33.20
LT Debt/Eq —
EPS (ttm) 2.01
EPS next Y 5.02
EPS Growth 26.90%
Revenue Growth 6.20%
EPS Gr Q/Q 25.40%
Rev Gr Q/Q —
Earnings (next) 2026-05-28
Earnings (prior) 2026-03-05
ROA 3.64%
ROE 4.87%
ROIC —
Gross Margin 65.44%
Oper. Margin 20.78%
Profit Margin 9.67%
Shs Outstand 195.11M
Shs Float 193.68M
Insider Own 0.62%
Instit Own 105.80%
Short Float 3.23%
Short Ratio 3.00
Short Interest 5.52M
52W High 89.83
vs 52W High -29.77%
52W Low 61.78
vs 52W Low 2.12%
Beta 1.07
Impl. Vol. 1.56%
Rel Volume 1.22
Avg Volume 2.01M
Volume 2.45M
Target (mean) $91.07
Tgt Median $95.00
Tgt Low $69.00
Tgt High $103.00
# Analysts 15
Recom Buy
Prev Close $64.34
Price $63.09
Change -1.94%
About

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$91.07
Mean price target
2. Current target
$63.09
Latest analyst target
3. DCF / Fair value
$33.87
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$63.09
Low
$69.00
High
$103.00
Mean
$91.07

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-06 main Citigroup Neutral → Neutral $87
2026-03-06 main Barclays Overweight → Overweight $103
2026-03-06 main Needham Buy → Buy $101
2026-02-03 main Needham Buy → Buy $99
2026-01-26 main Barclays Overweight → Overweight $98
2025-12-08 main Citigroup Neutral → Neutral $88
2025-12-08 main Morgan Stanley Equal-Weight → Equal-Weight $83
2025-12-08 main Goldman Sachs Sell → Sell $71
2025-12-05 reit Stifel Buy → Buy $95
2025-12-05 reit Piper Sandler Overweight → Overweight $94
2025-12-05 main Wells Fargo Equal-Weight → Equal-Weight $82
2025-12-05 main JP Morgan Neutral → Neutral $78
2025-12-05 main Mizuho Outperform → Outperform $100
2025-12-05 main Baird Outperform → Outperform $98
2025-12-05 main Needham Buy → Buy $100
2025-11-13 down Wells Fargo Overweight → Equal-Weight $72
2025-10-13 init Barclays — → Overweight $85
2025-10-01 init Goldman Sachs — → Sell $64
2025-08-28 main JP Morgan Neutral → Neutral $66
2025-08-28 main Morgan Stanley Equal-Weight → Equal-Weight $76
News
RSS: Latest COO news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-01 WEISS ROBERT S Director — 3,654 — —
2026-04-01 LUCCHESE CYNTHIA L Director — 3,322 — —
2026-04-01 MADDEN TERESA SMITH Director — 3,322 — —
2026-04-01 ROSEBROUGH WALTER M JR Director — 832 — —
2026-04-01 JAY COLLEEN E Director — 3,322 — —
2026-04-01 RIVAS MARIA Director — 3,322 — —
2026-04-01 CARBONE BARBARA Director — 3,050 — —
2026-04-01 KURZIUS LAWRENCE ERIK Director — 3,322 — —
2026-01-12 JAY COLLEEN E Director — 7,064 $39.40 $278,322
2026-01-08 WHITE ALBERT G III Chief Executive Officer — 18,340 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-10-31 2024-10-31 2023-10-31 2022-10-31
Total Revenue
4,092.40
+5.06%
3,895.40
+8.41%
3,593.20
+8.61%
3,308.40
Operating Revenue
4,092.40
+5.06%
3,895.40
+8.41%
3,593.20
+8.61%
3,308.40
Cost Of Revenue
1,410.30
+8.51%
1,299.70
+5.21%
1,235.30
+5.69%
1,168.80
Reconciled Cost Of Revenue
1,232.10
+9.44%
1,125.80
+6.83%
1,053.80
+5.15%
1,002.20
Gross Profit
2,682.10
+3.33%
2,595.70
+10.09%
2,357.90
+10.20%
2,139.60
Operating Expense
1,999.20
+5.78%
1,890.00
+3.57%
1,824.80
+11.81%
1,632.00
Research And Development
172.20
+11.03%
155.10
+12.88%
137.40
+24.57%
110.30
Selling General And Administration
1,627.80
+6.14%
1,533.70
+2.16%
1,501.20
+11.85%
1,342.20
General And Administrative Expense
—
—
—
—
Other Gand A
—
—
—
—
Total Expenses
3,409.50
+6.89%
3,189.70
+4.24%
3,060.10
+9.26%
2,800.80
Operating Income
682.90
-3.23%
705.70
+32.38%
533.10
+5.02%
507.60
Total Operating Income As Reported
682.90
-3.23%
705.70
+32.38%
533.10
+5.02%
507.60
EBITDA
1,043.90
-2.59%
1,071.70
+20.97%
885.90
+0.82%
878.70
Normalized EBITDA
1,051.90
-2.32%
1,076.90
+21.56%
885.90
+0.82%
878.70
Reconciled Depreciation
377.40
+0.61%
375.10
+2.01%
367.70
+6.24%
346.10
EBIT
666.50
-4.32%
696.60
+34.43%
518.20
-2.70%
532.60
Total Unusual Items
-8.00
-53.85%
-5.20
+25.71%
-7.00
-127.24%
25.70
Total Unusual Items Excluding Goodwill
-8.00
-53.85%
-5.20
+25.71%
-7.00
-127.24%
25.70
Special Income Charges
—
—
—
—
Impairment Of Capital Assets
—
—
—
—
Net Income
374.90
-4.44%
392.30
+33.34%
294.20
-23.74%
385.80
Pretax Income
566.50
-2.71%
582.30
+41.03%
412.90
-13.13%
475.30
Net Non Operating Interest Income Expense
-100.00
+12.51%
-114.30
-8.55%
-105.30
-83.77%
-57.30
Interest Expense Non Operating
100.00
-12.51%
114.30
+8.55%
105.30
+83.77%
57.30
Net Interest Income
-100.00
+12.51%
-114.30
-8.55%
-105.30
-83.77%
-57.30
Interest Expense
100.00
-12.51%
114.30
+8.55%
105.30
+83.77%
57.30
Other Income Expense
-16.40
-80.22%
-9.10
+38.93%
-14.90
-159.60%
25.00
Other Non Operating Income Expenses
-8.40
-115.38%
-3.90
+73.83%
-14.90
-159.60%
25.00
Gain On Sale Of Security
-8.00
-53.85%
-5.20
+25.71%
-7.00
-127.24%
25.70
Tax Provision
191.60
+0.84%
190.00
+60.07%
118.70
+32.63%
89.50
Tax Rate For Calcs
0.00
+3.68%
0.00
+13.40%
0.00
+52.67%
0.00
Tax Effect Of Unusual Items
-2.70
-59.51%
-1.70
0.00
0.00
Net Income Including Noncontrolling Interests
374.90
-4.44%
392.30
+33.34%
294.20
-23.74%
385.80
Net Income From Continuing Operation Net Minority Interest
374.90
-4.44%
392.30
+33.34%
294.20
-23.74%
385.80
Net Income From Continuing And Discontinued Operation
374.90
-4.44%
392.30
+33.34%
294.20
-23.74%
385.80
Net Income Continuous Operations
374.90
-4.44%
392.30
+33.34%
294.20
-23.74%
385.80
Normalized Income
380.20
-3.94%
395.80
+34.54%
294.20
-23.74%
385.80
Net Income Common Stockholders
374.90
-4.44%
392.30
+33.34%
294.20
-23.74%
385.80
Diluted EPS
1.87
-4.59%
1.96
+32.66%
1.48
-23.84%
1.94
Basic EPS
1.91
-2.63%
1.97
+32.34%
1.49
-24.09%
1.96
Basic Average Shares
195.90
-1.85%
199.60
+0.76%
198.10
+0.45%
197.20
Diluted Average Shares
200.00
-0.20%
200.40
+0.60%
199.20
+0.20%
198.80
Diluted NI Availto Com Stockholders
374.90
-4.44%
392.30
+33.34%
294.20
-23.74%
385.80
Amortization
199.20
-0.99%
201.20
+8.06%
186.20
+3.73%
179.50
Amortization Of Intangibles Income Statement
199.20
-0.99%
201.20
+8.06%
186.20
+3.73%
179.50
Depreciation Amortization Depletion Income Statement
199.20
-0.99%
201.20
+8.06%
186.20
+3.73%
179.50
Depreciation And Amortization In Income Statement
199.20
-0.99%
201.20
+8.06%
186.20
+3.73%
179.50
Earnings From Equity Interest
—
—
—
—
Gain On Sale Of PPE
—
—
—
—
Line Item Trend 2025-10-31 2024-10-31 2023-10-31 2022-10-31
Total Assets
12,394.80
+0.65%
12,315.20
+5.63%
11,658.90
+1.45%
11,492.30
Current Assets
2,106.40
+7.94%
1,951.50
+14.46%
1,704.90
+11.17%
1,533.60
Cash Cash Equivalents And Short Term Investments
110.60
+2.79%
107.60
-10.93%
120.80
-12.59%
138.20
Cash And Cash Equivalents
110.60
+2.79%
107.60
-10.93%
120.80
-12.59%
138.20
Cash Financial
—
—
—
—
Receivables
829.00
+15.62%
717.00
+17.60%
609.70
+9.30%
557.80
Accounts Receivable
829.00
+15.62%
717.00
+17.60%
609.70
+9.30%
557.80
Gross Accounts Receivable
880.90
+15.83%
760.50
+18.64%
641.00
+10.80%
578.50
Allowance For Doubtful Accounts Receivable
-51.90
-19.31%
-43.50
-38.98%
-31.30
-51.21%
-20.70
Inventory
846.00
+5.39%
802.70
+9.12%
735.60
+17.00%
628.70
Raw Materials
193.10
+2.60%
188.20
-9.21%
207.30
+19.34%
173.70
Work In Process
19.90
+7.57%
18.50
-2.63%
19.00
+25.00%
15.20
Finished Goods
633.00
+6.21%
596.00
+17.02%
509.30
+15.80%
439.80
Prepaid Assets
—
—
—
208.90
Assets Held For Sale Current
—
—
—
0.00
Other Current Assets
320.80
-1.05%
324.20
+35.76%
238.80
+14.31%
208.90
Total Non Current Assets
10,288.40
-0.73%
10,363.70
+4.12%
9,954.00
-0.05%
9,958.70
Net PPE
2,082.00
+11.73%
1,863.40
+14.14%
1,632.60
+13.94%
1,432.90
Gross PPE
3,908.40
+9.79%
3,559.90
+11.74%
3,185.90
+12.97%
2,820.10
Accumulated Depreciation
-1,826.40
-7.66%
-1,696.50
-9.22%
-1,553.30
-11.97%
-1,387.20
Properties
0.00
0.00
0.00
0.00
Land And Improvements
26.70
+5.95%
25.20
+24.75%
20.20
+8.02%
18.70
Buildings And Improvements
582.90
+4.59%
557.30
+14.08%
488.50
+17.54%
415.60
Machinery Furniture Equipment
2,684.90
+9.96%
2,441.70
+11.64%
2,187.10
+10.82%
1,973.60
Construction In Progress
611.80
+14.83%
532.80
+9.56%
486.30
+23.74%
393.00
Other Properties
2.10
-27.59%
2.90
-23.68%
3.80
-80.21%
19.20
Goodwill And Other Intangible Assets
5,439.70
-3.37%
5,629.40
+5.52%
5,334.80
-2.91%
5,494.80
Goodwill
3,853.40
+0.39%
3,838.40
+5.90%
3,624.50
+0.41%
3,609.70
Other Intangible Assets
1,586.30
-11.43%
1,791.00
+4.72%
1,710.30
-9.27%
1,885.10
Non Current Deferred Assets
2,077.50
-6.01%
2,210.30
-5.92%
2,349.50
-3.83%
2,443.10
Non Current Deferred Taxes Assets
2,077.50
-6.01%
2,210.30
-5.92%
2,349.50
-3.83%
2,443.10
Other Non Current Assets
689.20
+4.33%
660.60
+3.69%
637.10
+8.37%
587.90
Total Liabilities Net Minority Interest
4,155.70
-1.79%
4,231.60
+3.01%
4,107.90
-4.86%
4,317.60
Current Liabilities
1,112.80
+8.80%
1,022.80
+5.55%
969.00
-24.31%
1,280.20
Payables And Accrued Expenses
300.40
+15.32%
260.50
-0.53%
261.90
+5.27%
248.80
Payables
300.40
+15.32%
260.50
-0.53%
261.90
+5.27%
248.80
Accounts Payable
300.40
+15.32%
260.50
-0.53%
261.90
+5.27%
248.80
Employee Benefits
—
—
—
225.20
Pensionand Other Post Retirement Benefit Plans Current
210.60
+20.48%
174.80
+0.00%
174.80
+14.92%
152.10
Current Debt And Capital Lease Obligation
47.80
+43.54%
33.30
-26.65%
45.40
-89.00%
412.60
Current Debt
47.10
+46.27%
32.20
-27.48%
44.40
-88.78%
395.70
Other Current Borrowings
47.10
+46.27%
32.20
-27.48%
44.40
-86.86%
338.00
Current Capital Lease Obligation
0.70
-36.36%
1.10
+10.00%
1.00
-94.08%
16.90
Current Deferred Liabilities
127.90
-1.54%
129.90
+5.10%
123.60
+32.05%
93.60
Current Deferred Revenue
127.90
-1.54%
129.90
+5.10%
123.60
+32.05%
93.60
Other Current Liabilities
426.10
+0.42%
424.30
+16.79%
363.30
-2.63%
373.10
Total Non Current Liabilities Net Minority Interest
3,042.90
-5.17%
3,208.80
+2.23%
3,138.90
+3.34%
3,037.40
Long Term Debt And Capital Lease Obligation
2,457.50
-3.64%
2,550.40
+1.05%
2,523.80
+7.36%
2,350.80
Long Term Debt
2,455.70
-3.62%
2,548.00
+1.10%
2,520.40
+7.38%
2,347.10
Long Term Capital Lease Obligation
1.80
-25.00%
2.40
-29.41%
3.40
-8.11%
3.70
Non Current Pension And Other Postretirement Benefit Plans
—
—
—
225.20
Tradeand Other Payables Non Current
7.50
-86.96%
57.50
-36.25%
90.20
-20.32%
113.20
Non Current Deferred Liabilities
295.10
+2.00%
289.30
+1.26%
285.70
-17.95%
348.20
Non Current Deferred Revenue
201.80
+4.40%
193.30
+4.94%
184.20
-7.11%
198.30
Non Current Deferred Taxes Liabilities
93.30
-2.81%
96.00
-5.42%
101.50
-32.29%
149.90
Other Non Current Liabilities
282.80
-9.24%
311.60
+30.27%
239.20
+6.22%
225.20
Stockholders Equity
8,238.90
+1.92%
8,083.40
+7.05%
7,550.80
+5.24%
7,174.50
Common Stock Equity
8,238.90
+1.92%
8,083.40
+7.05%
7,550.80
+5.24%
7,174.50
Capital Stock
21.80
+0.46%
21.70
+0.46%
21.60
+300.00%
5.40
Common Stock
21.80
+0.46%
21.70
+0.46%
21.60
+300.00%
5.40
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
217.60
+0.18%
217.20
+0.70%
215.70
+0.23%
215.20
Ordinary Shares Number
195.90
-1.85%
199.60
+0.76%
198.10
+0.45%
197.20
Treasury Shares Number
21.70
+23.30%
17.60
+0.00%
17.60
-2.22%
18.00
Additional Paid In Capital
1,975.50
+2.84%
1,921.00
+5.71%
1,817.20
+2.93%
1,765.50
Retained Earnings
7,643.30
+5.16%
7,268.40
+5.71%
6,876.10
+4.42%
6,584.90
Gains Losses Not Affecting Retained Earnings
-406.50
+3.60%
-421.70
+7.07%
-453.80
+2.78%
-466.80
Treasury Stock
995.20
+40.96%
706.00
-0.61%
710.30
-0.59%
714.50
Minority Interest
0.20
+0.00%
0.20
+0.00%
0.20
+0.00%
0.20
Other Equity Adjustments
-406.50
+3.60%
-421.70
+7.07%
-453.80
+2.78%
-466.80
Total Equity Gross Minority Interest
8,239.10
+1.92%
8,083.60
+7.05%
7,551.00
+5.24%
7,174.70
Total Capitalization
10,694.60
+0.59%
10,631.40
+5.56%
10,071.20
+5.77%
9,521.60
Working Capital
993.60
+6.99%
928.70
+26.20%
735.90
+190.41%
253.40
Invested Capital
10,741.70
+0.73%
10,663.60
+5.42%
10,115.60
+2.00%
9,917.30
Total Debt
2,505.30
-3.03%
2,583.70
+0.56%
2,569.20
-7.03%
2,763.40
Net Debt
2,392.20
-3.25%
2,472.60
+1.17%
2,444.00
-6.17%
2,604.60
Capital Lease Obligations
2.50
-28.57%
3.50
-20.45%
4.40
-78.64%
20.60
Net Tangible Assets
2,799.20
+14.07%
2,454.00
+10.74%
2,216.00
+31.93%
1,679.70
Tangible Book Value
2,799.20
+14.07%
2,454.00
+10.74%
2,216.00
+31.93%
1,679.70
Line Of Credit
—
—
44.40
-23.05%
57.70
Line Item Trend 2025-10-31 2024-10-31 2023-10-31 2022-10-31
Operating Cash Flow
796.10
+12.24%
709.30
+16.76%
607.50
-12.26%
692.40
Cash Flow From Continuing Operating Activities
796.10
+12.24%
709.30
+16.76%
607.50
-12.26%
692.40
Net Income From Continuing Operations
374.90
-4.44%
392.30
+33.34%
294.20
-23.74%
385.80
Depreciation Amortization Depletion
377.40
+0.61%
375.10
+2.01%
367.70
+6.24%
346.10
Depreciation
178.20
+2.47%
173.90
-4.19%
181.50
+8.94%
166.60
Amortization Cash Flow
199.20
-0.99%
201.20
+8.06%
186.20
+3.73%
179.50
Depreciation And Amortization
377.40
+0.61%
375.10
+2.01%
367.70
+6.24%
346.10
Amortization Of Intangibles
199.20
-0.99%
201.20
+8.06%
186.20
+3.73%
179.50
Other Non Cash Items
45.60
+17.83%
38.70
+371.95%
8.20
-62.56%
21.90
Stock Based Compensation
70.50
-6.13%
75.10
+20.93%
62.10
+14.58%
54.20
Provisionand Write Offof Assets
—
—
—
—
Asset Impairment Charge
77.30
+80.19%
42.90
-13.16%
49.40
+997.78%
4.50
Deferred Tax
135.20
+13.71%
118.90
+166.00%
44.70
-17.07%
53.90
Deferred Income Tax
135.20
+13.71%
118.90
+166.00%
44.70
-17.07%
53.90
Gain Loss On Sale Of PPE
—
—
—
—
Change In Working Capital
-284.80
+14.65%
-333.70
-52.51%
-218.80
-25.75%
-174.00
Change In Receivables
-120.30
-2.73%
-117.10
-94.52%
-60.20
-78.11%
-33.80
Changes In Account Receivables
-120.30
-2.73%
-117.10
-94.52%
-60.20
-78.11%
-33.80
Change In Inventory
-46.00
+22.43%
-59.30
+43.74%
-105.40
-160.89%
-40.40
Change In Payables And Accrued Expense
-15.80
-532.00%
-2.50
-103.26%
76.80
+39.89%
54.90
Change In Accrued Expense
27.90
+675.00%
3.60
-94.99%
71.80
+121.60%
32.40
Change In Payable
-43.70
-616.39%
-6.10
-222.00%
5.00
-77.78%
22.50
Change In Account Payable
8.00
-13.98%
9.30
+69.09%
5.50
-88.98%
49.90
Change In Other Working Capital
-46.80
-10.38%
-42.40
-23.98%
-34.20
+66.99%
-103.60
Change In Other Current Assets
-74.50
+43.77%
-132.50
-48.21%
-89.40
-428.99%
-16.90
Change In Other Current Liabilities
18.60
-7.46%
20.10
+414.06%
-6.40
+81.29%
-34.20
Investing Cash Flow
-372.90
+51.23%
-764.60
-70.29%
-449.00
+75.48%
-1,831.20
Cash Flow From Continuing Investing Activities
-372.90
+51.23%
-764.60
-70.29%
-449.00
+75.48%
-1,831.20
Net PPE Purchase And Sale
-362.40
+13.96%
-421.20
-7.31%
-392.50
-62.19%
-242.00
Purchase Of PPE
-362.40
+13.96%
-421.20
-7.31%
-392.50
-62.19%
-242.00
Capital Expenditure
-362.40
+13.96%
-421.20
-7.31%
-392.50
-62.19%
-242.00
Net Business Purchase And Sale
-10.50
+96.94%
-343.40
-507.79%
-56.50
+96.44%
-1,589.20
Purchase Of Business
-10.50
+96.94%
-343.40
-507.79%
-56.50
+96.56%
-1,641.30
Financing Cash Flow
-425.90
-1186.48%
39.20
+122.54%
-173.90
-114.57%
1,193.70
Cash Flow From Continuing Financing Activities
-425.90
-1186.48%
39.20
+122.54%
-173.90
-114.57%
1,193.70
Net Issuance Payments Of Debt
-79.90
-1526.79%
5.60
+103.10%
-180.80
-114.14%
1,278.80
Issuance Of Debt
3,111.10
-11.72%
3,524.20
+65.91%
2,124.20
+40.58%
1,511.00
Repayment Of Debt
-3,205.20
+8.60%
-3,506.80
-79.48%
-1,953.90
-247.98%
-561.50
Long Term Debt Issuance
3,111.10
-11.72%
3,524.20
+65.91%
2,124.20
+40.58%
1,511.00
Long Term Debt Payments
-3,205.20
+8.60%
-3,506.80
-79.48%
-1,953.90
-247.98%
-561.50
Net Long Term Debt Issuance
-94.10
-640.80%
17.40
-89.78%
170.30
-82.06%
949.50
Net Short Term Debt Issuance
14.20
+220.34%
-11.80
+96.64%
-351.10
-206.62%
329.30
Net Common Stock Issuance
-290.10
0.00
0.00
+100.00%
-78.50
Common Stock Payments
-290.10
0.00
0.00
+100.00%
-78.50
Common Stock Dividend Paid
0.00
0.00
+100.00%
-3.00
+0.00%
-3.00
Cash Dividends Paid
0.00
0.00
+100.00%
-3.00
+0.00%
-3.00
Repurchase Of Capital Stock
-290.10
0.00
0.00
+100.00%
-78.50
Proceeds From Stock Option Exercised
-8.80
-126.19%
33.60
+239.39%
9.90
+1514.29%
-0.70
Net Other Financing Charges
-47.10
—
—
-2.90
Changes In Cash
-2.70
+83.23%
-16.10
-4.55%
-15.40
-128.05%
54.90
Effect Of Exchange Rate Changes
5.60
+93.10%
2.90
+226.09%
-2.30
+82.17%
-12.90
Beginning Cash Position
107.70
-10.92%
120.90
-12.77%
138.60
+43.48%
96.60
End Cash Position
110.60
+2.69%
107.70
-10.92%
120.90
-12.77%
138.60
Free Cash Flow
433.70
+50.54%
288.10
+34.00%
215.00
-52.26%
450.40
Interest Paid Supplemental Data
115.10
-14.61%
134.80
+14.72%
117.50
+139.31%
49.10
Income Tax Paid Supplemental Data
100.00
+27.55%
78.40
+15.63%
67.80
+1.80%
66.60
Change In Income Tax Payable
-51.70
-235.71%
-15.40
-2980.00%
-0.50
+98.18%
-27.40
Change In Tax Payable
-51.70
-235.71%
-15.40
-2980.00%
-0.50
+98.18%
-27.40
Sale Of Business
—
0.00
0.00
-100.00%
52.10
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category